EVOMELA 50 mg/10mL
Melphalan · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · Acrotech Biopharma Inc
Evomela is a chemotherapy medication containing melphalan that is administered intravenously to treat certain blood cancers and multiple myeloma. It works by damaging cancer cell DNA to slow or stop cancer growth.
Key Facts
- Brand Name
- EVOMELA
- Generic Name
- Melphalan
- NDC Code (Product)
72893-001- Manufacturer
- Acrotech Biopharma Inc
- Strength
- 50 mg/10mL
- Dosage Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- NDA207155
- Marketing Start
- 03/31/2016
Recall History
No Recall HistoryFrequently Asked Questions
What is EVOMELA used for?
Evomela is a chemotherapy medication containing melphalan that is administered intravenously to treat certain blood cancers and multiple myeloma. It works by damaging cancer cell DNA to slow or stop cancer growth.
Is EVOMELA a controlled substance?
EVOMELA is not classified as a controlled substance by the DEA.
What is the generic name for EVOMELA?
The generic name for EVOMELA is Melphalan. There are 12 other brand versions of Melphalan.
What is the NDC code for EVOMELA 50 mg/10mL?
The NDC (National Drug Code) for EVOMELA 50 mg/10mL is 72893-001, listed by Acrotech Biopharma Inc.